Please try another search
Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops medicines for hyperkinetic movement disorders and other rare diseases. The company specializes in applying deuterium chemistry to known molecules to create novel therapies. Its portfolio includes Austedo (SD-809), a solution for the potential treatment of chorea associated with Huntington's disease, tardive dyskinesia, and Tourette syndrome; SD-560, a solution for fibrotic conditions; and SD-1077, a solution for Parkinson's disease. The company was founded in 2001 and is headquartered in San Diego, California. As of May 5, 2015, Auspex Pharmaceuticals, Inc. operates as a subsidiary of Teva Pharmaceutical Industries Limited.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review